Sibutramine (Meridia™)

Previous | Next

Mechanism of Action

  • SNRI developed as antidepressant

Dose

  • 5, 10, or 15mg daily

Evidence

  • Cochrane review; 5 RCTs x 1 year

  • Wt loss vs. placebo 4.3kg (3.6 - 4.9)

  • ß 4.6% of baseline wt ³

  • 10% wt loss = 15% (4-27)

Adverse Effects

  • Ý BP & pulse

Reference

  • Padwal, et al. Cochrane Database Syst Rev. 2004;(3):CD004094

Previous | Next